Retour aux projets

17616.1 PFLS-LS

17616.1 PFLS-LS

Résumé

New therapeutic approach to Alzheimer's disease: assessing active immunization and anti-aggregation small molecules in a novel mouse model of Tau pathology

Textes supplémentaires

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disease with increasing incidence due to an aging world population and an absence of disease-modifying therapies. Our objective is to develop a novel genetic mouse model to demonstrate efficacy of therapeutics (small molecules and vaccines) to prevent the progression of the Tau pathology in order to evaluate their therapeutic value for testing in AD patients.

Participants

Andreas Muhs

Wirtschaftspartner

AC Immune SA Andreas Muhs Bâtiment B / EPFL Innovation Park 1015 Lausanne VD CH

Bernard Schneider

Kontaktperson

bernard.schneider@epfl.ch

EPFL IC IIF LABOS Bernard Schneider Station 9, Bâtiment AI 2241 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-08-31
Date de fin
2018-08-31
Coûts totaux approuvés
CHF 385553.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%